Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.650
+0.050 (1.09%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Treace Medical Concepts Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 205.31 | 212.69 | 209.36 | 187.12 | 141.84 | 94.42 | |
Revenue Growth | -3.95% | 1.59% | 11.88% | 31.92% | 50.22% | 64.59% |
Cost of Revenue | 42.19 | 42.94 | 41.09 | 35.18 | 25.53 | 16.89 |
Gross Profit | 163.12 | 169.75 | 168.26 | 151.94 | 116.31 | 77.53 |
Selling, General & Admin | 198.62 | 203.62 | 201.26 | 187.93 | 137.57 | 83.84 |
Research & Development | 18.22 | 20.28 | 20.59 | 15.44 | 13.58 | 10.2 |
Operating Expenses | 216.84 | 223.91 | 223.95 | 203.37 | 151.15 | 94.04 |
Operating Income | -53.72 | -54.15 | -55.69 | -51.43 | -34.84 | -16.51 |
Interest Expense | -5.82 | -5.32 | -5.26 | -5.17 | -4.4 | -4.06 |
Interest & Investment Income | 2.11 | 2.78 | 4.88 | 6.73 | 1.31 | 0.02 |
Other Non Operating Income (Expenses) | 0.66 | 0.43 | 0.32 | 0.34 | -0.06 | 0 |
EBT Excluding Unusual Items | -56.78 | -56.27 | -55.74 | -49.53 | -37.99 | -20.55 |
Asset Writedown | - | - | - | - | -0.35 | - |
Other Unusual Items | -2.74 | -2.74 | - | - | -4.48 | - |
Pretax Income | -59.52 | -59 | -55.74 | -49.53 | -42.82 | -20.55 |
Net Income | -59.52 | -59 | -55.74 | -49.53 | -42.82 | -20.55 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.2 |
Net Income to Common | -59.52 | -59 | -55.74 | -49.53 | -42.82 | -20.75 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 64 | 63 | 62 | 61 | 55 | 48 |
Shares Outstanding (Diluted) | 64 | 63 | 62 | 61 | 55 | 48 |
Shares Change | 2.71% | 1.86% | 2.07% | 10.09% | 14.17% | 30.61% |
EPS (Basic) | -0.93 | -0.93 | -0.90 | -0.81 | -0.77 | -0.43 |
EPS (Diluted) | -0.93 | -0.93 | -0.90 | -0.81 | -0.77 | -0.43 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -25.05 | -29.49 | -48.76 | -46.03 | -45.49 | -19.9 |
Free Cash Flow Per Share | -0.39 | -0.47 | -0.79 | -0.76 | -0.82 | -0.41 |
Gross Margin | 79.45% | 79.81% | 80.37% | 81.20% | 82.00% | 82.11% |
Operating Margin | -26.17% | -25.46% | -26.60% | -27.48% | -24.57% | -17.49% |
Profit Margin | -28.99% | -27.74% | -26.63% | -26.47% | -30.19% | -21.97% |
Free Cash Flow Margin | -12.20% | -13.86% | -23.29% | -24.60% | -32.07% | -21.07% |
EBITDA | -46.35 | -44.53 | -48.27 | -46.58 | -32.71 | -15.83 |
EBITDA Margin | -22.58% | -20.94% | -23.06% | -24.89% | -23.06% | -16.76% |
D&A For EBITDA | 7.37 | 9.62 | 7.42 | 4.85 | 2.13 | 0.69 |
EBIT | -53.72 | -54.15 | -55.69 | -51.43 | -34.84 | -16.51 |
EBIT Margin | -26.17% | -25.46% | -26.60% | -27.48% | -24.57% | -17.49% |
Advertising Expenses | - | 6.6 | 14.8 | 16.1 | 15 | 13 |